𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Research strategies to improve snakebite treatment: Challenges and progress

✍ Scribed by Robert A. Harrison; Darren A. Cook; Camila Renjifo; Nicholas R. Casewell; Rachel B. Currier; Simon C. Wagstaff

Publisher
Elsevier
Year
2011
Tongue
English
Weight
631 KB
Volume
74
Category
Article
ISSN
1874-3919

No coin nor oath required. For personal study only.

✦ Synopsis

Antivenom is an effective treatment of snakebite but, because of the complex interplay of fiscal, epidemiological, therapeutic efficacy and safety issues, the mortality of snakebite remains unacceptably high. Efficiently combating this high level of preventable death amongst the world's most disadvantaged communities requires the globally-coordinated action of multiple intervention programmes. This is the overall objective of the Global Snakebite Initiative. This paper describes the challenges facing the research community to develop snakebite treatments that are more efficacious, safe and affordable than current therapy.

📜 SIMILAR VOLUMES

ChemInform Abstract: Catalysis Research
ChemInform Abstract: Catalysis Research of Relevance to Carbon Management: Progress, Challenges, and Opportunities
✍ Tobin J. Marks; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 24 KB 👁 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v

Report on a single-topic conference on “
Report on a single-topic conference on “Chronic Viral Hepatitis–Strategies to Improve Effectiveness of Screening and Treatment”
✍ John W. Ward; Anna S.F. Lok; David L. Thomas; Hashem B. El-Serag; W. Ray Kim 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

and Roche and has received grants from Bristol-Myers Squibb, GlaxoSmithKline, Gilead, Roche, and Merck. David Thomas has been a consultant for Merck and has received grants from Gilead and Merck. Hashem El-Serag has been a consultant for Vertex and has received grants from Bayer and Abbott. Ray Kim

Improving tumor-to-normal-tissue ratios
Improving tumor-to-normal-tissue ratios of antibodies by extracorporeal immunoadsorption based on the avidin-biotin concept : Development of a new treatment strategy applied to monoclonal antibodies murine L6 and chimeric BR96
✍ Jan Tennvall; Michael Garkavij; JianQing Chen; Hans Olov Sjögren; Sven-Erik Stra 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB 👁 1 views

## Background: Several strategies have been explored to accelerate monoclonal antibody (mab) conjugate clearance without affecting intratumoral uptake. one of the most promising is extracorporeal immunoadsorption (ecia), in which excess radiolabeled mab circulating in blood is removed. ## Methods: